Risk of recurrence and bleeding in patients with cancer-associated venous thromboembolism in the direct oral anticoagulants era: Findings from the TULIPE registry.

Risk of recurrence and bleeding in patients with cancer-associated venous thromboembolism in the direct oral anticoagulants era: Findings from the TULIPE registry.

Show other versions (1)

<h4>Background</h4>The introduction of direct oral anticoagulants (DOACs) for venous thromboembolism (VTE) treatment has led to their widespread adoption in clinical practice, potentially influencing management strategies and patient outcomes. However, real-world data on cancer-associate...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuki Ishizuka, Kazuko Tajiri, Hiroyuki Naito, Momoko Murata, Masayuki Hattori, Tomoko Machino-Ohtsuka, Tomoko Ishizu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0329025
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1371/journal.pone.0329025

Similar Items